Complimentary 340B program review
Led by pharmacists, built for rural and critical access hospitals. We look at your contract pharmacy claims, TPA (third-party administrator) settings, 340B ESP designations, drug pricing, and compliance, then show your leadership what we found and what it is worth.
From the team behind Citizens 340B, critical access hospital-to-critical access hospital consulting.
Rural and critical access hospital 340B programs, managed end to end.
Pharmacists and 340B specialists who manage hospital programs every day.
Working inside a Kansas critical access hospital, serving the rural communities we live in.
With your approval, we fix what we can during the review: missing ESP designations, Medicaid exclusions, prescriber lists.
What we check
We review your program the way we run the ones we manage: claim by claim.
Most contract pharmacies miss eligible prescriptions, and the dispensing fee decides whether the captured ones make money. We check both and show what your fees cost per dollar of 340B revenue.
Without consistent updating, the eligible prescriber list loaded into your TPA no longer accurately reflects your true medical staff, and eligible prescriptions stop qualifying. We reconcile the list and check whether specialist referrals are being captured.
Your TPA decides which claims you ever see. We look at how your TPA is performing and how it compares to the programs we manage. We can also make TPA recommendations.
Missing designations in 340B ESP, the manufacturers' restriction portal, cut off discounts on the medications your community fills most. We find the gaps, submit the designations with your approval, and confirm the pricing comes through.
For hospitals that carve out Medicaid, a Medicaid claim captured as 340B is a duplicate discount, one of the most common HRSA audit findings. We match every captured claim against verified Medicaid plan lists for your state and its neighbors.
Vaccines, supplies, and test strips that run through the program add fees and complicate your contract pharmacy inventory management, with little or no savings. We flag them, along with any policy gaps an auditor would find.
What recent reviews found
Most of what we find traces back to one thing: 340B program management has become a full-time specialty, and most critical access hospitals do not have full-time staff to give it. Manufacturer restrictions, TPA settings, Medicaid rules, and drug pricing change faster than anyone can track part-time.
Critical access hospital, one contract pharmacy, nine months of claims
in eligible prescriptions from the hospital's own prescribers that were never captured
manufacturers designated in 340B ESP during the review, up from six honoring 340B pricing before it
prescribers missing from the TPA list, including the entire visiting cardiology service
Critical access hospital, one contract pharmacy, eight months of claims
of the pharmacy's prescriptions filtered out by the TPA before anyone at the hospital could see them
a year in profitable, eligible prescriptions that were never captured
claims bought at the wrong 340B price, including one at $5,966 that should have cost about 30 cents
From the written findings delivered to each hospital in October 2026, with identifiers removed and Medicaid claims excluded. The yearly figure projects the review period forward.
How it works
Twenty minutes to understand your program and contract pharmacies. Before any data moves, we both sign a business associate agreement (BAA).
Our pharmacists and analysts review your data and compare your program with the ones we manage.
A written report your board can follow, and a call to walk through what to fix first and what each fix is worth.
The review is complimentary and carries no obligation. The findings, files, and fixes are yours whether or not you work with us.
The software
Today our team does this work by hand from TPA reports, wholesaler catalogs, and hospital records. The MAP 340B platform will make it faster, more consistent, and visible to the hospitals we serve.
First release in developmentEvery contract pharmacy claim will be screened against your prescriber history, and our analysts will document the referral behind each qualified claim.
Wholesaler 340B prices will be checked against ceiling prices, with a flag whenever a manufacturer's 340B price disappears from a pharmacy account.
HRSA's rebate pilot begins January 1, 2027. The platform will track each pilot claim and match the rebate to the payment received, so you can show the money came back.
Contract pharmacy invoices, fees, and amounts owed will live in one place, with overdue balances flagged early.
Hospitals that work with us will get portal access as the platform rolls out.
Who we are
MAP 340B is a pharmacist-led consulting and software company in Colby, Kansas, focused entirely on the 340B program. We manage more than 70 programs end to end for rural and critical access hospitals: contract pharmacies, TPA oversight, referral capture, audits, and policies.
Founder Paul Schiferl, PharmD, BCPS, also serves as the 340B coordinator for Citizens Medical Center. The team includes pharmacists, certified pharmacy technicians, a nurse, and analysts with hospital and retail pharmacy experience. The same people who run our clients' programs every day perform these reviews.
Ongoing management runs under Citizens 340B, our consulting practice with Citizens Medical Center, a critical access hospital in Colby, Kansas.
Visit Citizens 340BPaul Schiferl, PharmD, BCPS
Common questions
Yes. You do not have to change vendors. The review is a second set of eyes on capture, designations, and compliance, and the findings are yours to share with whoever manages your program.
No. Most of what we find comes from how complicated 340B has become and how little time a critical access hospital can give it. We document what changed, fix what we can with your approval, and the credit for a stronger program stays with your team.
Only the pharmacists and analysts on your review, using accounts your hospital issues and can remove at any time, after a signed BAA.
This is how we meet hospitals. If the findings show work worth doing, we will offer to help under a separate agreement. Many hospitals take us up on it. None have to.
A written report: executive summary, the numbers behind each finding, what was fixed during the review, and an action plan in priority order. We walk through it with your leadership on a call.
Most reviews are delivered within a few weeks of access being granted.
We send introductions from map340breview.com so outreach stays separate from our work with client hospitals. Every message comes from a member of our team, usually offering a complimentary review. If you would rather not hear from us, reply with the word unsubscribe or use the link in the email, and we will remove you right away.
Request your complimentary review
After a short call and a signed BAA, findings usually follow within a few weeks.
MAP 340B · 100 E. College Drive, Colby, Kansas 67701
